Mathematical models for kinetics of radiopharmaceuticals in humans were developed and are used to estimate the radiation absorbed dose for patients in nuclear medicine by the International Commission on Radiological Protection and the Medical Internal Radiation Dose (MIRD) Committee. However, due to the fact that the residence times used were derived from different subjects, partially even with different ethnic backgrounds, a large variation in the model parameters propagates to a high uncertainty of the dose estimation. In this work, a method was developed for analysing the uncertainty and sensitivity of biokinetic models that are used to calculate the residence times. The biokinetic model of 18 F-FDG (FDG) developed by the MIRD Committee was analysed by this developed method. The sources of uncertainty of all model parameters were evaluated based on the experiments. The Latin hypercube sampling technique was used to sample the parameters for model input. Kinetic modelling of FDG in humans was performed. Sensitivity of model parameters was indicated by combining the model input and output, using regression and partial correlation analysis. The transfer rate parameter of plasma to other tissue fast is the parameter with the greatest influence on the residence time of plasma. Optimisation of biokinetic data acquisition in the clinical practice by exploitation of the sensitivity of model parameters obtained in this study is discussed.
INTRODUCTION
Mathematical and biokinetic or compartmental models are developed by the International Commission on Radiological Protection and the Medical Internal Radiation Dose (MIRD) Committee. These models are used to calculate the residence time or cumulated activity in the source organ per unit administered activity, which is further combined with the so-called S values, for estimation of patient organ absorbed dose received from radiopharmaceuticals (1 -3) . The uncertainties of the parameters, which contribute to the absorbed dose uncertainty, can be allocated to two main parts. At first, the parameters in biokinetic models are generally derived from laboratory animals or directly from patients who undergo the nuclear medicine procedure or healthy volunteers. They represent the uptake, distribution and retention of the radiopharmaceuticals in organs and tissues. The second part is the mass and position of the organs and tissues which are implicitly included in the S values (4) . In the present work, a method developed for analysing the uncertainty and sensitivity of the biokinetic models used in diagnostic nuclear medicine is described. This method is further applied to the biokinetic model of radiopharmaceutical 18 F-FDG (FDG) developed by the MIRD Committee, (5) which is widely used clinically and scientifically. Uncertainty of model prediction and model parameter sensitivity are presented with the intention of an optimisation of PET imaging acquisitions in the clinical practice.
MATERIALS AND METHODS

MIRD biokinetic models for radiopharmaceuticals
The MIRD Committee developed a biokinetic model for FDG radiopharmaceutical (5) , which is shown in Figure 1 . This model was analysed in the present study.
Uncertainty and sensitivity analysis of biokinetic models
Uncertainty analysis is the computation of the total uncertainty induced in the output by quantified uncertainty in the inputs and models, and the attributes of the relative importance of the input uncertainties in terms of their contributions, whereas sensitivity analysis is the computation of the effect of changes in input values or assumptions, including boundaries and model functional form, on the outputs (6) . The following five steps were included in the analysis.
(1) Uncertainty of input: The sources of uncertainty of model parameters were carefully analysed and evaluated. Model structure is one uncertain factor, which was not included in the present study. The ranges and distributions of FDG model parameters were based on experimental measurement done by the MIRD Committee (5) . (2) Sampling: Sampling techniques are needed to generate samples of the model input parameters (variables). Generally, the random, such as Monte Carlo simulation, or the stratified, such as the Latin hypercube sampling (LHS) (7) , sampling techniques are applied. In the present study, the LHS was used because it can improve the efficiency of Monte Carlo simulations by picking the input samples better and samples the entire domain more systematically. (3) Modelling: To predict the kinetics and retentions of FDG in humans, biokinetic modelling is required. A computer program (BIOKINDOSused for biokinetic modelling and internal dose calculation) was written, and several hundreds of computer simulations were performed with the sampled input parameters. A sample size of 500 was chosen, so that it is 95 % confident that the actual 97.5th percentile of the model output is between 96th and 99th percentiles (6) . (4) Uncertainty of output: Model predictions for different organs and tissues at different time periods resulted in huge amounts of data. For a better presentation of this data, the percentile was used for data reduction and to interpret the uncertainty of the results. For each organ and tissue at a different time point, modelled data are presented as 2.5th, 50th and 97.5th percentiles for comprising the 95 % confidence interval of the results. (5) Sensitivity of parameter: In order to identify the most influential parameter in the model, the concepts of the standardised rank regression coefficient (SRRC) and the partial rank correlation coefficient (PRCC) (8) were used. The SRRC can be computed by constructing regression models, which approximate the rank transformations of the sampled model input and output variables. The PRCC measures the rank correlation between one defined output variable with an input variable, under the condition that the indirect influence on this defined output variable due to other further input variables is somehow eliminated.
RESULTS AND DISCUSSION
The ranges and distributions of model parameters are presented in Table 1 . The distribution of the transfer rate was assigned to be a normal distribution with one standard deviation of the mean. Parameters of x15 and x17 were assumed to be a lognormal distribution due to the very low minimum values.
The mean value, variance and percentile of FDG retention in organs and tissues at different time periods were calculated based on the uncertainty presented in Table 1 . As an example, the uncertainty of the retention for compartments plasma, myocardium, white matter fast, other tissue fast and liver fast are predicted in Figure 2a . To present quantitatively the uncertainty of model predictions of organ FDG retentions, the uncertainty factor (UF) introduced by Leggett (9) was applied. With the assumptions that A stands for the value at 2.5th percentile, B for 50th percentile and C for 97.5th percentile, the mean UF (maximum of B/A and C/B) ranged from 1.3 for plasma retention to 8.3 for the liver slow compartment. The greater uncertainty of the retention function in liver compartments reflects the greater uncertainty of transfer rate parameters from plasma to liver fast, and from liver fast to liver slow. For retention function in the brain, represented as compartments of white matter and grey matter, the UF was about 2. The same factor of 2 was found for erythrocytes (RBCs) and for myocardium as well. The UF for the remainder organs and tissues was about 1.5. The sensitivity of each compartment influenced by all model input parameters was calculated and indicated as SRRC and PRCC. As an example, the impact indicated as PRCC of the most influential model parameters on the compartment plasma retention at different time periods is presented in Figure 2b . It is demonstrated that model input parameters influence the retentions of FDG in organs or tissues at different time periods in a different strength. Parameters of x1 and x2 influence the plasma retention strongly in the first 3 min, then the impact is reduced after 5-6 min. Parameter x12 is the most impact transfer rate on plasma retention during the whole time period. Parameters of x8, x9, x13 and x14 begin to have influences on the plasma retention not before 10 min; after 150 min, x8 and x9 lose their impact, whereas the impacts of x13 and x14 last till 500 min. Parameters which are not shown in Figure 2b contribute smaller impact (say, PRCC , 0.5) on the plasma retention. As a conclusion, the parameter x12 influences the plasma retention at the most.
The impact of parameters on the residence time of each compartment after a single bolus injection of FGD is indicated as SRRC and listed in Table 2 . The parameters of x12 and x13 have an overall impact on more residence times in the model, followed by parameter x14. However, for the residence time in the liver, parameter x15 influences mostly; for myocardium, parameter x18 is of utmost importance; for lungs, parameter x19 plays an important role. It showed that for the residence time in a single organ or tissue, the parameters directly connected with this organ or tissue impact strongly, among them one Table 1 .
parameter contributes at the most. Parameters x7, x11 and x16 are least influential on residence times.
The impact of the model parameter on the residence time has been further applied by Li et al. (10) in the uncertainty analysis of the organ absorbed dose of patients received from the radiopharmaceutical of FDG who undergo the diagnosis in nuclear medicine.
PET imaging is used to identify tumours and to search for metastases by intravenous injection of radionuclide into blood circulation of the living human body. However, a high radiation dose to the healthy organs and tissues should be avoided. The data collection in the design and protocol in PET or SPECT study is the first and most important phase. The statistical basis of a data acquisition protocol designed for dosimetry requires that an adequate number of data points be obtained and that the timing of these points be carefully selected (11) . The comprehensive information on uncertainty and the influence of parameters attained in the present study might be exploited for an efficient PET imaging data acquisition of the important organ and non-imaging data collection at different time periods. As shown in Figure 2a , the greater uncertainty in liver requires much more accurate imaging data acquisition. The sensitivity of parameters x12, x13 and x14 on plasma retention, shown in Figure 2b , suggests that the 'unmeasured tissue' (5) should carefully be evaluated from other 'measured tissues' at various times post administration; additional scan on other organs may reduce the influence of those remainder tissues on plasma retention. Strong impact of parameters x1 and x2 on FDG retention in grey matter of the brain in the first 5 min (not shown) suggests that dynamic tomographic imaging scans on the brain and blood sampling might be taken immediately after the injection.
The model predictions provide superior information for the FDG retention in organs; however, the model is derived from results of measurements. Therefore, uncertainties in the measurements should carefully be analysed according to the standard guidance (12) to ensure a reliable model. In contrast to other methods, e.g. population approach (13) , the advantage of the sensitivity analysis performed in the present study indicates the most influential parameter on the time-dependent model prediction.
CONCLUSION
In this study, a practical method was developed for analysis of uncertainty and sensitivity of biokinetic models for radiopharmaceuticals used in nuclear medicine. As an example, the method was applied to analyse the biokinetic model of FDG developed by the MIRD Committee. The PET imaging data acquisition and excreta counting in the clinical practice can be optimised by exploitation of the uncertainty and sensitivity of model parameters obtained in this study.
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